RWE and Patient-Centered Outcomes

Widespread availability of real-world data has enabled the generation of evidence and insights that benefit patients, providers, plans, and industry. When that evidence reflects patient outcomes, it provides an invaluable perspective on the consumer experience. Explore our real-world evidence (RWE) analyses and guidance to support your strategic decisions.

Patient–Provider Collaboration: Shared Decision Making in Cancer Care

In the latest installment of Avalere’s ongoing insight series about shared decision making, Michelle Bruno, Associate Principal in Avalere’s Center for Healthcare Transformation, describes the role it can play in cancer care.

Medicare Beneficiary Care Differences by Practice Ownership

Avalere released a white paper analyzing spending and utilization among Medicare beneficiaries receiving care from independent physician practices and hospital-owned physician practices in Ohio.

Alex Du Joins Avalere Health’s Market Access Practice

Avalere Health welcomes Alex (Shuang) Du as an associate principal to its Market Access practice. He will support a variety of Avalere’s clients in navigating the evolving healthcare landscape.

Massey Whorley

Majority of API in US-Consumed Medicines Is Produced in the US

Analysis of the most recent available trade data finds that 53% of API, in dollars, used in domestically consumed medicines came from the US in 2020.

Treating Depression Reduces Medicare Costs; Provider Challenges Remain

A recent Avalere analysis of Medicare Fee-for-Service (FFS) data illustrates that treating major depressive disorder (MDD) in Medicare-eligible beneficiaries results in a 4% reduction in total cost compared to untreated patients, highlighting the importance of incentivizing adequate provider supply and payment in the geriatric psychiatry market.

Admissions From EDs Increased for FFS Beneficiaries in 2020

In 2020, the total number of emergency department (ED) visits for Medicare fee-for-service (FFS) beneficiaries declined, but patients presenting with non-emergency care sensitive conditions were more likely to be admitted than in 2019.

Utilization Management Trends in the Commercial Market, 2014–2020

A new Avalere analysis examines the prevalence of utilization management (UM) in the commercial market from 2014 to 2020, focusing on drugs treating cancer, autoimmune diseases, and a range of other chronic conditions.

Brigit Kyei-Baffour

Digital Health Advances Create Opportunities for Access and Engagement

Digital health solutions continue to advance the way healthcare is delivered. Through research and development as well as stakeholder partnerships, life science companies can leverage digital health technologies to optimize access along the patient care journey.

Elizabet Shvets

Rare and Orphan Disease Therapies Require New Distribution Strategies

Manufacturers currently in the developmental phase for drug assets targeting rare or orphan diseases should assess the commercialization implications when bringing novel therapies to market and how they may differ from the standard pharmaceutical supply chain and economics.

AI in Healthcare: Raise the Evidence Bar Now or Be Forced to Later

In 2012, experts predicted that artificial Intelligence (AI) would eventually replace as much as 80% of current clinical practice by physicians. While AI has certainly expanded in healthcare—especially during the COVID-19 pandemic—the last few years have included some eventful setbacks in the use of AI across several sectors of the economy, including healthcare.

Interview: Infusing the Patient Perspective into Value Assessment, Part III

Tune into another episode of Avalere Health Essential Voice in our Start Your Day with Avalere series. In the final segment of our series on infusing the patient perspective into value assessment, our experts discuss the Patient Perspective Value Framework (PPVF) developed by Avalere Health and FasterCures, which employs a form of multi-criteria decision analysis to capture value according to patients.

Video: COVID-19 and Oncology Care

Tune into another episode in the Avalere Health Essential Voice series focused on disease education. In this segment, experts from Community Oncology Alliance (COA) and Texas Oncology join us to discuss the impact of COVID-19 on oncology care from a provider and patient perspective.

Interview: COVID-19 and Oncology Care

Tune into another episode in the Avalere Health Essential Voice podcast series focused on disease education. In this segment, experts from Community Oncology Alliance (COA) and Texas Oncology join us to discuss the impact of COVID-19 on oncology care from a provider and patient perspective.

Interview: Infusing the Patient Perspective into Value Assessment, Part II

Tune into another episode of Avalere Health Essential Voice in our Start Your Day with Avalere series. In this segment, we continue our series on infusing the patient perspective into value assessment with a discussion on the need for a solution to incorporating value drivers outside of traditional endpoints, and introduce a proposed approach to quantify those elements of healthcare value.

Interview: Infusing the Patient Perspective into Value Assessment, Part I

Tune into another episode of Avalere Health Essential Voice in our Start Your Day with Avalere series. In this segment, our experts kick off a three-part series about patient perspective in value assessment with an overview of value assessments and value frameworks.

Interview: Senior Health and Well-Being During COVID-19

Tune into another episode in the Avalere Health Essential Voice podcast series focused on COVID-19. In this segment, Richard Ashworth, President and CEO of Tivity Health, joins us to discuss survey findings around COVID-19 and the senior population, with key takeaways related to vaccination acceptance and hesitancy.

Sign up to receive more insights about RWE and Patient-Centered Outcomes
Please enter your email address to be notified when new RWE and Patient-Centered Outcomes insights are published.

Back To Top